Tacrolimus API Market

Tacrolimus API Market contains market size and forecasts of Tacrolimus API in global, including the following market information:

• Global Tacrolimus API Market Revenue, 2018-2023, 2023-2030, ($ millions)
• Global Tacrolimus API Market Sales, 2018-2023, 2023-2030, (Tons)
• Global top five Tacrolimus API companies in 2022 (%)

The global Tacrolimus API market was valued at million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.

The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.

0.98 Segment to Reach $ Million by 2030, with a % CAGR in next six years.

The global key manufacturers of Tacrolimus API include Hangzhou Zhongmei Huadong Pharmaceutical, Guangzhou Tosun Pharmaceutical, Chunghwa Chemical Synthesis & Biotech, ChemWerth Inc, Dr. Reddy's Laboratories, Zeon Health Industries, Fishfa Biogenics, Teva API and Apotex Fermentation Inc., etc. In 2022, the global top five players have a share approximately % in terms of revenue.

We surveyed the Tacrolimus API manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Tacrolimus API Market, by Purity, 2018-2023, 2023-2030 ($ Millions) & (Tons)

Global Tacrolimus API Market Segment Percentages, by Purity, 2022 (%)

• 0.98
• 0.99
• Others

Global Tacrolimus API Market, by Application, 2018-2023, 2023-2030 ($ Millions) & (Tons)

Global Tacrolimus API Market Segment Percentages, by Application, 2022 (%)

• Capsules
• Injection
• Ointments
• Eye Drops
• Others

Global Tacrolimus API Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions) & (Tons)

Global Tacrolimus API Market Segment Percentages, By Region and Country, 2022 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Tacrolimus API revenues in global market, 2018-2023 (Estimated), ($ millions)
• Key companies Tacrolimus API revenues share in global market, 2022 (%)
• Key companies Tacrolimus API sales in global market, 2018-2023 (Estimated), (Tons)
• Key companies Tacrolimus API sales share in global market, 2022 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Hangzhou Zhongmei Huadong Pharmaceutical
• Guangzhou Tosun Pharmaceutical
• Chunghwa Chemical Synthesis & Biotech
• ChemWerth Inc
• Dr. Reddy's Laboratories
• Zeon Health Industries
• Fishfa Biogenics
• Teva API
• Apotex Fermentation Inc.
• Astellas Pharma
• Bills Biotech
• CKD Bio Corporation
• Concord Biotech
• JOYANG LABORATORIES
• Lek Pharmaceuticals
• Murli Krishna Pharma
• Viruj Pharmaceuticals Pvt. Ltd
• Zhejiang Hisun Pharmaceutical